Buyback Spend for Bio-Techne (TECH)
Buyback Spend for Bio-Techne (TECH): headline value $200.15M · YoY +244.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingBuyback SpendSwitch metric
Latest period
$200.15M
YoY change
+244.5%
5Y CAGR
+40.6%
Peak year (2025)
$275.73M
Latest annual
$275.73M
Buyback Spend history chart for Bio-Techne (TECH) from 1990 to 2025
Buyback Spend history table for Bio-Techne (TECH) from 1990 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $275.73M | +244.5% | ||
| 2024 | $80.04M | +309.2% | ||
| 2023 | $19.56M | -87.8% | ||
| 2022 | $160.95M | +272.8% | ||
| 2021 | $43.18M | -13.8% | ||
| 2020 | $50.11M | +225.3% | ||
| 2019 | $15.40M | — | ||
| 2018 | $0 | — | ||
| 2017 | $0 | — | ||
| 2016 | $0 | — | ||
| 2015 | $0 | — | ||
| 2014 | $0 | -100.0% | ||
| 2013 | $2.39M | -90.2% | ||
| 2012 | $24.50M | +996.9% | ||
| 2011 | $2.23M | -85.7% | ||
| 2010 | $15.58M | -83.1% | ||
| 2009 | $92.31M | +53.4% | ||
| 2008 | $60.19M | +4825.7% | ||
| 2007 | $1.22M | -95.5% | ||
| 2006 | $27.27M | -73.8% | ||
| 2005 | $103.93M | — | ||
| 2004 | $0 | -100.0% | ||
| 2003 | $23.66M | +3073.5% | ||
| 2002 | $745,615 | -35.9% | ||
| 2001 | $1.16M | — | ||
| 2000 | $0 | -100.0% | ||
| 1999 | $3.90M | +1200.0% | ||
| 1998 | $300,000 | -90.6% | ||
| 1997 | $3.20M | +357.1% | ||
| 1996 | $700,000 | +16.7% | ||
| 1995 | $600,000 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | -100.0% | ||
| 1992 | $200,000 | — | ||
| 1991 | $0 | -100.0% | ||
| 1990 | $200,000 | — |
Buyback Spend values are taken from Bio-Techne's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Bio-Techne (TECH) most recent annual buyback spend stands at $275.73M (2025) – surged 244.5% year-over-year.
Over 2020–2025 (5 years), Bio-Techne buyback spend expanded at a +40.6% compound annual rate, sustaining 2 straight years of year-over-year growth.
$275.73M stands as the all-time-high annual buyback spend, posted in 2025, against a low of $0 during 1991.
Bio-Techne (TECH) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $2.75B.
Bio-Techne Buyback Spend by Year
Bio-Techne Buyback Spend 2025: $275.73M
Bio-Techne buyback spend in 2025 was $275.73M, surged 244.5% from 2024. This figure represents the highest annual value in the available history.
Bio-Techne Buyback Spend 2024: $80.04M
Bio-Techne buyback spend in 2024 was $80.04M, surged 309.2% from 2023.
Bio-Techne Buyback Spend 2023: $19.56M
Bio-Techne buyback spend in 2023 was $19.56M, plunged 87.8% below 2022.
Bio-Techne Buyback Spend 2022: $160.95M
Bio-Techne buyback spend in 2022 was $160.95M, surged 272.8% from 2021.
Bio-Techne Buyback Spend 2021: $43.18M
Bio-Techne buyback spend in 2021 was $43.18M.
See more financial history for Bio-Techne (TECH).
Sector peers — Buyback Spend
Companies in the same sector as Bio-Techne, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Bio-Techne's buyback spend?
Latest reported buyback spend for Bio-Techne (TECH) is $200.15M (period ending December 31, 2025).
How has Bio-Techne buyback spend changed year-over-year?
Bio-Techne (TECH) buyback spend changed +244.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne buyback spend?
Bio-Techne (TECH) buyback spend compound annual growth rate is +40.6% over the most recent 5 years available.
When did Bio-Techne buyback spend hit its highest annual value?
Bio-Techne buyback spend reached its highest annual value of $275.73M in 2025.
What was Bio-Techne buyback spend in 2024?
Bio-Techne (TECH) buyback spend in 2024 was $80.04M.
What was Bio-Techne buyback spend in 2025?
Bio-Techne (TECH) buyback spend in 2025 was $275.73M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.